𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Detection of Serum Aberrant CDKN2/P16 DNA in Colorectal Cancer

✍ Scribed by Xiaobo LIANG; Yongchang LIU; Junning SUN; Yi FENG

Book ID
106314375
Publisher
Springer
Year
2005
Tongue
English
Weight
164 KB
Volume
4
Category
Article
ISSN
1610-1979

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Molecular detection of p16 promoter meth
Molecular detection of p16 promoter methylation in the serum of recurrent colorectal cancer patients
✍ Hiroshi Nakayama; Kenji Hibi; Tsunenobu Takase; Taiji Yamazaki; Yasushi Kasai; K πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 73 KB πŸ‘ 1 views

## Abstract We previously proved that p16 promoter methylation present in the tumors of colorectal cancer patients can be detected in the serum of those same patients using methylation‐specific PCR (MSP). To seek the possibility that this technique could be applied to the monitoring of cancer recur

Alterations of CDKN2 (p16) in non-small
Alterations of CDKN2 (p16) in non-small cell lung cancer
✍ Sven De Vos; Carl W. Miller; Seisho Takeuchi; Adrian F. Gombart; Steve K. Cho; H πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 567 KB

## Abstract The cyclin‐dependent kinase inhibitor known as __p16__ (__CDK41, CDKN2, INK4A, MTS1__) has been proposed as a tumor suppressor gene on chromosome segment 9p21. We have evaluated __CDKN2__ alterations in 34 non‐small cell lung cancers (NSCLCs) with matched normal tissue controls and in 9